SBLOF (Shin Nippon Biomedical Laboratories) 10-Year RORE % : 23.71% (As of Mar. 2026)


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
74 GF Score
Price $9.16
GF Value $14.04
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories 10-Year RORE %?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 74 10-Year RORE % is 23.71 as of Mar. 2026. GuruFocus rates SBLOF with a GF Score™ of 74/100 and a GF Value™ of $14.04. The stock has 5 warning signs investors should review. Among 121 Medical Diagnostics & Research companies, Shin Nippon Biomedical Laboratories ranks better than 84.3% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Shin Nippon Biomedical Laboratories's 10-Year RORE % for the quarter that ended in Mar. 2026 was 23.71%.

The industry rank for Shin Nippon Biomedical Laboratories's 10-Year RORE % or its related term are showing as below:

SBLOF's 10-Year RORE % is ranked better than
84.3% of 121 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.83 vs SBLOF: 23.71

Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Shin Nippon Biomedical Laboratories 10-Year RORE % Related Terms


Shin Nippon Biomedical Laboratories 10-Year RORE % Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories 10-Year RORE % Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.56 46.04 32.04 6.20 23.71

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.20 30.72 26.62 27.80 23.71

SBLOF vs TMO, DHR, IDXX: 10-Year RORE % Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories 10-Year RORE % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's 10-Year RORE % falls into.


SBLOF
74GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
10-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories 10-Year RORE % Calculation

Shin Nippon Biomedical Laboratories's 10-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( 0.707--0.268 )/( 5.73-1.617 )
=0.975/4.113
=23.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.

Frequently Asked Questions Learn more about 10-Year RORE % →
What does a 10-Year RORE % of 23.71 mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a 10-Year RORE % of 23.71 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Shin Nippon Biomedical Laboratories and its competitors. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #19 out of 121 companies in the Medical Diagnostics & Research industry, placing it in the top 15.7%.
Is Shin Nippon Biomedical Laboratories' 10-Year RORE % too high?
Shin Nippon Biomedical Laboratories' current 10-Year RORE % is 23.71. The Medical Diagnostics & Research industry median 10-Year RORE % is 0.83. Shin Nippon Biomedical Laboratories' value of 23.71 is 2756.6% above this industry median. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #19 out of 121 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' 10-Year RORE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #19 out of 121 companies for 10-Year RORE %. This places Shin Nippon Biomedical Laboratories in the top 16% of its industry — outperforming the majority of peers. The industry median 10-Year RORE % is 0.83. Shin Nippon Biomedical Laboratories' value of 23.71 is 2756.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Medical Diagnostics & Research company?
The median 10-Year RORE % among Medical Diagnostics & Research companies is 0.83, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shin Nippon Biomedical Laboratories's current 10-Year RORE % of 23.71 is 2756.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Shin Nippon Biomedical Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median 10-Year RORE % is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shin Nippon Biomedical Laboratories's current 10-Year RORE % is 23.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current 10-Year RORE % of 23.71. The stock's GF Value™ is $14.04, compared to a current price of $9.16 — trading 34.8% below its estimated fair value. The current 10-Year RORE % is 23.71 and 2756.6% above the Medical Diagnostics & Research industry median of 0.83. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current 10-Year RORE % is 23.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 34.8% below its estimated GF Value™ of $14.04.

Key valuation signals for SBLOF:

  • 10-Year RORE %: 23.71
  • GF Value™: $14.04 vs. price of $9.16 (34.8% below fair value)
  • GF Score™: 74/100 with 5 warning signs
  • Industry Position: 2756.6% above the Medical Diagnostics & Research median (#19 of 121)

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score

Get the complete analysis for SBLOF

10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$14.04
GF Value